Endo International | ENDP - درآمد فروش



حراجی تغییر دادن تاریخ
AbbVie USD 16.62B 840M 2025-12
Amarin USD 49.22M 451K 2025-12
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.86B 50M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Xeris Pharmaceuticals USD 85.81M 11.43M 2025-12
Zoetis USD 2.4B 0 2025-12